One trial 14 had a high risk of bias for efficacy outcomes due to missing outcome data
PubMed Nauck, M.A., Quast, D.R., Wefers, J., & Meier, J.J
A 30-year-old likely has far fewer senescent cells than a 60-year-old, which means: Younger individuals may notice less from FOXO4-DRI simply because there are fewer target cells to clear Older individuals or those with conditions associated with accelerated senescence (chronic inflammation, metabolic syndrome, prior chemotherapy) may have more to gain and more pronounced initial side effects from a larger clearance event Overall Health and Immune Function The immune system must clear apoptotic cells after FOXO4-DRI triggers their death
Our study found that none of the six eryptosis inducers presented the ability to induce eryptosis hallmarks, either in nave or in P
(2007) This foundational laboratory study demonstrated that the related peptide AHK-Cu directly stimulates hair follicle elongation and protects dermal papilla cells from apoptosis (caspase-3 reduced 42.7%, PARP reduced 77.5%)
Skip what slows you down
)
